A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease
Eisai Inc.
Eisai Inc.
University of California, San Francisco
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
INSYS Therapeutics Inc
Vanderbilt-Ingram Cancer Center